- Home
- IFRX vs VRA Comparison
IFRX vs VRA Comparison
Compare IFRX & VRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- VRA
- Stock Information
- Founded
- IFRX 2007
- VRA 1982
- Country
- IFRX Germany
- VRA United States
- Employees
- IFRX N/A
- VRA N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- VRA Apparel
- Sector
- IFRX Health Care
- VRA Consumer Discretionary
- Exchange
- IFRX Nasdaq
- VRA Nasdaq
- Market Cap
- IFRX 65.8M
- VRA 69.2M
- IPO Year
- IFRX 2017
- VRA 2010
- Fundamental
- Price
- IFRX $1.30
- VRA $1.94
- Analyst Decision
- IFRX Strong Buy
- VRA Strong Buy
- Analyst Count
- IFRX 2
- VRA 2
- Target Price
- IFRX $9.00
- VRA $4.00
- AVG Volume (30 Days)
- IFRX 322.6K
- VRA 242.3K
- Earning Date
- IFRX 05-07-2025
- VRA 06-11-2025
- Dividend Yield
- IFRX N/A
- VRA N/A
- EPS Growth
- IFRX N/A
- VRA N/A
- EPS
- IFRX N/A
- VRA N/A
- Revenue
- IFRX $171,642.00
- VRA $371,967,000.00
- Revenue This Year
- IFRX $106.72
- VRA N/A
- Revenue Next Year
- IFRX $66.89
- VRA $4.53
- P/E Ratio
- IFRX N/A
- VRA N/A
- Revenue Growth
- IFRX 162.79
- VRA N/A
- 52 Week Low
- IFRX $0.82
- VRA $1.73
- 52 Week High
- IFRX $2.82
- VRA $8.32
- Technical
- Relative Strength Index (RSI)
- IFRX 58.32
- VRA 40.85
- Support Level
- IFRX $0.82
- VRA $1.73
- Resistance Level
- IFRX $1.12
- VRA $2.10
- Average True Range (ATR)
- IFRX 0.13
- VRA 0.19
- MACD
- IFRX 0.06
- VRA 0.03
- Stochastic Oscillator
- IFRX 90.49
- VRA 39.62
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About VRA Vera Bradley Inc.
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the most. most of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.